Celgene (CELG) Tops Q4 EPS by 7c, Offers FY Guidance

Go back to Celgene (CELG) Tops Q4 EPS by 7c, Offers FY Guidance

Celgene (CELG) PT Raised to $98 at RBC Capital

February 1, 2019 6:40 AM EST

RBC Capital analyst Brian Abrahams raised the price target on Celgene (NASDAQ: CELG) to $98.00 (from $96.00) while maintaining a Sector Perform rating.

Abrahams notes key boxes are being checked to facilitated the BMY acquisition.

... More